Andere Sprachen Bio-Rad Laboratories, Inc. Nyse

Aktien

862449

US0905721082

BIO.B

Markt geschlossen - Nyse Andere Börsenplätze 22:15:00 17.05.2024			% 5 Tage	% 1. Jan.
279.9 ^USD	0.00%		0.00%	-12.71%

14.05.	Transcript : Bio-Rad Laboratories, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:05 PM
08.05.	BIO-RAD LABORATORIES, INC. : UBS bleibt bei seiner Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	08.05.
Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline	07.05.
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 Revenue $610.8M, vs. Street Est of $620.1M	07.05.
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 EPS $2.29, vs. Street Est of $2.14	07.05.
Bio-Rad: Q1 Earnings Snapshot	07.05.
Bio-Rad Reports First-Quarter 2024 Financial Results	07.05.
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07.05.
Bio-Rad's Management to Participate in Fireside Chat during RBC Capital Markets Global Healthcare Conference	02.05.
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference	01.05.
Bio-Rad Announces Life Science Group Management Changes	29.04.
Bio-Rad Announces Life Science Group Management Changes	26.04.
Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	26.04.
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	18.04.
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	15.04.
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	11.04.
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	11.04.
Bio-Rad Laboratories COO Andrew Last to Retire in September	10.04.
Bio-Rad’s Chief Operating Officer Andrew Last to Retire	10.04.
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	10.04.
North American Morning Briefing : Focus Turns to -2-	04.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Rad Laboratories, Inc. Nyse

Aktien

862449

US0905721082

BIO.B

Andere Sprachen

Filter